HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

anaxirone

structure given in first source

Also Known As:

1,2,4-TGU; 1,2,4-triglycidyl urazol; NSC 332488; 1,2,4-Triazolidine-3,5-dione, 1,2,4-tris(oxiranylmethyl)-

Networked: 4 relevant articles (0 outcomes, 4 trials/studies)

Bio-Agent Context: Research Results

Heterocyclic Compounds: 198
- 1-Ring Heterocyclic Compounds
  - Azoles: 2138
    - Triazoles: 1533
      - anaxirone: 4

Related Diseases

1.	Colorectal Neoplasms (Colorectal Cancer) 01/01/1994 - "Phase II trial of anaxirone (TGU) in advanced colorectal cancer: an EORTC Early Clinical Trials Group (ECTG) study." 01/01/1994 - "Anaxirone is inactive in metastatic colorectal cancer." 01/01/1994 - "Anaxirone, a rationally synthesised triepoxide derivative, was given to 46 patients with metastatic colorectal cancer. "
2.	Neoplasms (Cancer) 06/01/1987 - "Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study."
3.	Renal Cell Carcinoma (Grawitz Tumor) 06/01/1986 - "Primary resistance of renal adenocarcinoma to 1,2,4-triglycidylurazol (TGU, NSC 332488), a new triexpoxide cytostatic agent--a phase II study of the EORTC early clinical trials group."
4.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 05/01/1987 - "Phase II trial of anaxirone in advanced non-small cell lung cancer."
5.	Carcinoma (Carcinomatosis) 06/01/1987 - "Sixteen patients with advanced ovarian carcinoma were treated with anaxirone (1,2,4-triglycidylurazol, TGU), 600 mg/m2 every 4 weeks. " 06/01/1987 - "Phase II trial of anaxirone (1,2,4-triglycidylurazol, TGU) in patients with advanced ovarian carcinoma: an EORTC Gynecological Cancer Cooperative Group Study."

Related Drugs and Biologics

1.	Cytostatic Agents